Report Feature
The future of the protein engineering market looks promising with opportunities in biopharmaceutical companies, contract research organizations, and academic research institutes. The global protein engineering market is expected to grow with a CAGR of 14%-18% from 2020 to 2025. The major drivers for this market are rise in investment in synthetic biology and increasing protein-based drug development by pharmaceutical & biotechnology companies.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein engineering market report, please download the report brochure.
In this market, instruments is the largest product & service segment of protein engineering, whereas biopharmaceutical companies is the largest end user. Growth in various segments of the protein engineering market are given below:
The study includes trends and forecast for the global protein engineering market by product & service, protein type, technology, end user, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Instruments
- Consumables
- Software & Services
By Protein Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Monoclonal Antibodies
- Erythropoietin
- Interferons
- Vaccines
- Colony-Stimulating Factors
- Growth Hormones
- Coagulation Factors
- Other Proteins
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Rational Protein Design
- Irrational Protein Design
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biopharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the protein engineering model companies profiled in this report include Bio-Rad Laboratories, Thermo Fisher Scientific, Agilent Technologies, Danaher, PerkinElmer, GE Healthcare Merck, and GenScript.
Lucintel forecasts that instruments will remain the largest product & service segment over the forecast period due to the extensive usage of new technologies and process advancements in proteomic research and high preference for automated technology by researchers in order to facilitate a faster molecule development process.
Within this market, biopharmaceutical companies will remain the largest end user segment over the forecast period due to the wide use of protein engineering in drug discovery and development of models to develop a broad range of protein-based drugs.
North America will remain the largest region over the forecast period due to the presence of a large number of pharmaceutical and biotechnology companies & a well-established healthcare market, rising R&D expenditure, and the availability of the latest techniques & instruments for drug discovery research in the region.
|
Features of the Global Protein Engineering Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein engineering market by product & service (instruments, consumables, and software & services), protein type (monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins), technology (rational protein design and irrational protein design), end user (biopharmaceutical companies, contract research organizations, and academic research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein engineering market? Q.5 What are the business risks and threats to the global protein engineering market? Q.6 What are the emerging trends in this protein engineering market and the reasons behind them? Q.7 What are some changing demands of customers in this protein engineering market? Q.8 What are the new developments in this protein engineering market? Which companies are leading these developments? Q.9 Who are the major players in this protein engineering market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive product and processes in this protein engineering market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global protein engineering market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product & Service & Service (Instruments, Consumables, and Software & Services), Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins), Technology (Rational Protein Design and Irrational Protein Design), and End User (Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Protein Engineering Market
4.1 Global Protein Engineering Market by Region
4.2.1 Market by Product & Service: Instruments, Consumables, and Software & Services
4.2.2 Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.2.3 Market by Technology: Rational Protein Design and Irrational Protein Design
4.2.4 Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.2.5 The United States Protein Engineering Market
4.2.6 The Canadian Protein Engineering Market
4.2.7 The Mexican Protein Engineering Market
4.3.1 Market by Product & Service: Instruments, Consumables, and Software & Services
4.3.2 Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.3.3 Market by Technology: Rational Protein Design and Irrational Protein Design
4.3.4 Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.3.5 The United Kingdom Protein Engineering Market
4.3.6 The Spanish Protein Engineering Market
4.3.7 The German Protein Engineering Market
4.3.8 The French Protein Engineering Market
4.4.1 Market by Product & Service: Instruments, Consumables, and Software & Services
4.4.2 Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.4.3 Market by Technology: Rational Protein Design and Irrational Protein Design
4.4.4 Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.4.5 The Chinese Protein Engineering Market
4.4.6 The Indian Protein Engineering Market
4.4.7 The Japanese Protein Engineering Market
4.5.1 Market by Product & Service: Instruments, Consumables, and Software & Services
4.5.2 Market by Protein Type: Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Other Proteins
4.5.3 Market by Technology: Rational Protein Design and Irrational Protein Design
4.5.4 Market by End User: Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes
4.5.5 Brazilian Protein Engineering Market
7.1.1 Growth Opportunities for the Global Protein Engineering Market by Product & Service
7.1.2 Growth Opportunities for the Global Protein Engineering Market by Protein Type
7.1.3 Growth Opportunities for the Global Protein Engineering Market by Technology
7.1.4 Growth Opportunities for the Global Protein Engineering Market by End User
7.1.5 Growth Opportunities for the Global Protein Engineering Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
